DEA Certification Category 1 CME Course: Safer Prescribing of Controlled Drugs - Opioids / Benzodiazepines / Psychostimulants

Once registered, click on the Tests Tab, then Launch Video.  Note: Viewing of the videos can be completed in one sitting or you may stop and resume at a later time/date. Please make a note where you left off as you will need to advance to that point upon return.  The entire video must be watched in order to claim credit.

You do not have to complete all of the modules at one time. You can complete one, then return to watch other modules at another time. You must watch the module video in its entirety and complete the post-test (attestation) to receive credit.  Once you've viewed all of the modules, you will then need to click on the Tests tab again to complete the post-test (attestation), evaluation and credit claim.

 

Activity Description
On December 29, 2022, the Consolidated Appropriations Act of 2023 enacted a new one-time, eight-hour training requirement for all Drug Enforcement Administration (DEA)-registered practitioners on the treatment and management of patients with opioid or other substance use disorders. The DEA Certification Category 1 CME Course: Safer Prescribing of Controlled Drugs - Opioids / Benzodiazepines / Psychostimulants 8 hour course was specifically developed to help physician and advanced practice prescribers meet this new one-time requirement for all DEA-registered practitioners.

 

The ongoing opioid epidemic is a top priority for physicians and organized medicine. In addition, clinicians report discomfort regarding benzodiazepine and psychostimulant prescribing challenges. To address the problem head-on, this course has been designed for physicians in all specialties, to help them increase their knowledge and ability to effectively prescribe controlled medications that have abuse potential, with the intention to provide appropriate and safe access to controlled prescription medications while limiting diversion, abuse, dependence and liability.

Agenda
What Makes a Controlled Drug a Controlled Drug, and How to Safely Prescribe Them (1.0 Hour Credit)
Theodore Parran, MD

Patients with Substance Use Disorder Moderate to Severe and Their Unique Risks Regarding Control Drug Exposure (1.0 Hour Credit)
Theodore Parran, MD

Opioids, Benzodiazepines and Psychostimulants: Controlled Drug Pharmacology, Initiation, Titration, Tapering and Withdrawal Management (1.5 Hour Credit)
Theodore Parran, MD

Basic Principles of Safe Prescribing: Indications, Contraindications, Clinical Reasoning, and Monitoring (1 Hour Credit)
Theodore Parran, MD

Opiate Use Disorder: Special Considerations Regarding Buprenorphine and Methadone (1.0 Hour Credit)
Theodore Parran, MD

Legal Issues: Perspective of Defense (1.50 Hours Credit)
John Irwin, JD, MD, FCLM

Summary: Maintaining Boundaries for Safer Prescribing of Controlled Drugs: Practical Applications to Clinical Practice (1 Hour Credit)
Theodore Parran, MD

Planning Committee
Course Director
Theodore V. Parran, Jr., MD, FACP
Carter and Isabel Wong Professor of Medical Education
Case Western Reserve University School of Medicine
Dr. Parran, planner for this educational event, has no relevant financial relationship(s) with ineligible companies to disclose.

Amy Ross Pisman
Director
Continuing Medical Education Program
Case Western Reserve University School of Medicine
Ms. Pisman, planner for this educational event, has no relevant financial relationship(s) with ineligible companies to disclose.

Faculty
Course Director
Theodore V. Parran, Jr., MD, FACP
Carter and Isabel Wong Professor of Medical Education
Case Western Reserve University School of Medicine
Dr. Parran, faculty for this educational event, has no relevant financial relationship(s) with ineligible companies to disclose.

John R. Irwin, JD, MD, FCLM
Attorney at Law
Dr. Irwin, faculty for this educational event, has no relevant financial relationship(s) with ineligible companies to disclose.

Thursday, June 1, 2023, 8:00 AM - Sunday, May 31, 2026, 4:00 PM, Online

1. Describe the common pharmacologic properties of all controlled drugs
2. Identify and emphasize the legal duties of physicians as prescribers of controlled substances
3. Outline the mechanism of addictive action of controlled drugs
4. Demonstrate application of safe clinical reasoning to decisions regarding controlled drug prescribing

Online Enduring Material:  $100

Case Western Reserve University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Case Western Reserve University School of Medicine designates this enduring material for a maximum of 8.00 AMA PRA Category 1^™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ (8.00 hours), Non-Physician Attendance (8.00 hours)

Mitigation of Relevant Financial Relationships

CWRU School of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.